Phase II Trial of Ofatumumab and Fresh Frozen Plasma in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 11 Jan 2018
At a glance
- Drugs Ofatumumab (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 05 Jan 2018 Planned End Date changed from 1 Jan 2018 to 1 May 2018.
- 05 Jan 2018 Planned primary completion date changed from 1 Dec 2016 to 1 May 2018.
- 05 Jul 2017 Status changed from recruiting to active, no longer recruiting.